5 Potential Winners In The ‘New Normal’ Economy

These 5 companies could give your portfolio a boost. Here’s why.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

city

This week saw the departure of Sir Charlie Bean, Deputy Governor of the Bank of England, and in his final interview he stated that the ‘new normal’ interest rate could be as low as 2.5%.

Part of the reason for this is the vast amount of borrowing that UK businesses and individuals currently have, as well as the economy’s sluggish response to the credit crunch, which together mean that an ‘old normal’ rate of 5% may be a long way off.

With that in mind, here are five shares that could benefit from continued low rates.

GlaxoSmithKline

The last few years have been tough for savers, with savings rates being very low. The ‘new normal’ rate of 2.5%, although better, remains relatively unattractive. So shares that offer both a high yield and impressive dividend growth prospects could turn out to be winners.

One such example is GlaxoSmithKline (LSE: GSK). It currently yields 5.2% but its highly attractive drug pipeline means that long-term profitability prospects are very encouraging. As a result, GlaxoSmithKline’s dividend per share could increase at a brisk pace and make the shares more highly demanded, which could also help the share price to head northwards.

British American Tobacco

One beneficiary of low interest rates are companies with high debt levels. Such a  company is British American Tobacco (LSE: BATS), which currently has a debt to equity ratio of 176% — in other words, for every £1 of equity, the business has £1.76 of debt.

Although this seems high, the stability of British American Tobacco’s revenues makes it manageable, while a low interest rate should help to reduce interest charges, thereby increasing company profits. As with GlaxoSmithKline, a yield of 4.2% should also lead to buoyant demand for shares in the company.

The Retail Sector

Clearly, under ‘new normal’ conditions of low interest rates, there is less incentive to save and more incentive to spend. Therefore, retailers such as Sports Direct (LSE: SPD), Marks & Spencer (LSE: MKS) and Debenhams (LSE: DEB) should stand to benefit.

Certainly, Sports Direct is the best performer of the three at present, with the company set to report five consecutive years of earnings growth next year. It also remains attractive when its valuation and growth potential are taken into account, with a price to earnings growth (PEG) ratio of just 0.7 providing evidence of this.

Meanwhile, Debenhams and Marks & Spencer continue to struggle with their respective top-lines. The turnaround story at Marks & Spencer has disappointed many investors, but progress is being made, albeit slowly and its shares continue to offer strong income — a 4.1% yield — and good value  — a price to earnings (P/E) ratio of 12.7 —  at current levels.

Although shares in Debenhams have fallen heavily over the last six months, it too has potential. Recent news included Sports Direct and Costa Coffee concessions within stores, as well as a renewed focus on the company’s multi-channel offering and international expansion. Trading on a P/E of just 9.3, its shares offer great long-term value.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Peter owns shares in GlaxoSmithKline and Marks & Spencer. The Motley Fool has recommended GlaxoSmithKline.

More on Investing Articles

Investing Articles

This FTSE sell-off gives me an unmissable chance to buy cut-price UK stocks!

The last few months have been tough for UK stocks and their troubles aren't over yet, but Harvey Jones isn't…

Read more »

Investing Articles

Here’s the forecast for the Tesla share price as Trump’s policies take focus

The Tesla share price surged following Donald Trump’s election victory, but the stock is trading far above analysts’ targets. Dr…

Read more »

Investing Articles

£15,000 in cash? I’d pick growth stocks like these for life-changing passive income

Millions of us invest for passive income. Here, Dr James Fox explains his recipe for success by focusing on high-potential…

Read more »

Passive income text with pin graph chart on business table
Investing Articles

Here’s my plan for long-term passive income

On the lookout for passive income stocks to buy, Stephen Wright is turning to one of Warren Buffett’s most famous…

Read more »

artificial intelligence investing algorithms
Growth Shares

Are British stock market investors missing out on the tech revolution?

British stock market investors continue to pile into ‘old-economy’ stocks. Is this a mistake in today’s increasingly digital world?

Read more »

Fireworks display in the shape of willow at Newcastle, Co. Down , Northern Ireland at Halloween.
Investing Articles

My 2 best US growth stocks to buy in November

I’ve just bought two US growth companies on my best stocks to buy now list, and I think they’re still…

Read more »

Investing Articles

£2k in savings? Here’s how I’d invest that to target a passive income of £4,629 a year

Harvey Jones examines how investing a modest sum like £2,000 and leaving it to grow for years can generate an…

Read more »

Renewable energies concept collage
Investing Articles

Down 20%! A sinking dividend stock to buy for passive income?

This dividend stock is spending £50m buying back its own shares while they trade at a discount and also planning…

Read more »